切换至 "中华医学电子期刊资源库"

第五届中国出版政府奖音像电子网络出版物奖提名奖

中国科技核心期刊

中国科学引文数据库(CSCD)来源期刊

中华重症医学电子杂志 ›› 2020, Vol. 06 ›› Issue (01) : 92 -95. doi: 10.3877/cma.j.issn.2096-1537.2020.028

所属专题: 重症营养 文献

综述

参附注射液在危重症患者中的应用进展
司向1, 管向东1,()   
  1. 1. 510080 广州,中山大学附属第一医院重症医学科
  • 收稿日期:2019-12-10 出版日期:2020-02-28
  • 通信作者: 管向东
  • 基金资助:
    吴阶平医学基金会临床科研专项资助基金(320.6750.18037, 320.6750.18068); 广东省科技计划项目(2017B020247002)

Application of Shenfu injection in critically ill patients

Xiang Si1, Xiangdong Guan1,()   

  1. 1. Department of Critical Care Medicine, the First Affiliated Hospital, Sun Yat-Sen University, Guangzhou 510080, China
  • Received:2019-12-10 Published:2020-02-28
  • Corresponding author: Xiangdong Guan
  • About author:
    Corresponding author: Guan Xiangdong, Email:
引用本文:

司向, 管向东. 参附注射液在危重症患者中的应用进展[J/OL]. 中华重症医学电子杂志, 2020, 06(01): 92-95.

Xiang Si, Xiangdong Guan. Application of Shenfu injection in critically ill patients[J/OL]. Chinese Journal of Critical Care & Intensive Care Medicine(Electronic Edition), 2020, 06(01): 92-95.

参附注射液是我国传统医学和现代医学融合发展的结晶,随着近些年对其作用机制的不断探索及临床研究的逐渐深入,其适用范围不断拓展,尤其在救治急危重症患者中的有效性和安全性不断得到肯定,日益受到学者们的关注。本文就参附注射液的作用机制以及在危重症患者,特别是休克及心肺复苏患者中的应用进行综述,以期对将来基础医学和临床研究有所帮助。

The Shenfu injection (SFI) is the integration of Chinese traditional medicine and modern medicine. Recently, with the continuous exploration of its mechanism of pharmaceutical activity and the gradual deepening of clinical research, the application of SFI has been expanding. Especially in the treatment of critically ill patients, its effectiveness and safety has been constantly affirmed, and has attracted increasing attention of scholars. This article reviewed the mechanism of SFI and its application in critically ill patients, especially those with shock and cardiopulmonary resuscitation, in order to promote further basic medicine and clinical research in the future.

1
Yang H, Liu L, Gao W, et al. Direct and comprehensive analysis of ginsenosides and diterpene alkaloids in Shenfu injection by combinatory liquid chromatography-mass pectrometric techniques [J]. J Pharm Biom Anal, 2014, 92: 13-21.
2
Xiao Y, Ma ZC, Wang YG,et al. Cardioprotection of Shenfu preparata on cardiac myocytes through cytochrome P450 2J3 [J]. J Integr Med, 2013, 11(5): 327-336.
3
Ni J, Shi Y, Li L, et al. Cardioprotection against heart failure by Shenfu injection via TGF-β/Smads signaling pathway [J]. Evid Based Complement Alternat Med, 2017, 2017: 7083016.
4
Ji XF, Ji HB, Sang DY, et al. Shen-Fu injection reduces impaired myocardial β-adrenergic receptor signaling after cardiopulmonary resuscitation [J]. Chin Med J (Engl), 2013, 126(4): 697-702.
5
Gu W, Li C, Yin W, et al. Shen-fu injection reduces postresuscitation myocardial dysfunction in a porcine model of cardiac arrest by modulating apoptosis [J]. Shock, 2012, 38(3): 301-306.
6
Wu J, Li C, Yuan W. Effects of Shenfu injection on macrocirculation and microcirculation during cardiopulmonary resuscitation [J]. J Ethnopharmacol, 2016, 180: 97-103.
7
Wu Y, Xia ZY, Meng QT, et al. Shen-Fu injection preconditioning inhibits myocardial ischemia-reperfusion injury in diabetic rats: activation of eNOS via the PI3K/Akt pathway [J]. J Biomed Biotechnol, 2011, 2011: 384627.
8
Ji XF, Yang L, Zhang MY, et al. Shen-fuinjection attenuates postresuscitation myocardial dysfunction in a porcine model of cardiac arrest [J]. Shock, 2011, 35(5): 530-536.
9
Zhang Q, Li CS, Wang S, et al. Effects of Chinese medicine shen-fu injection on the expression of inflammatory cytokines and complements during post-resuscitation immune dysfunction in aporcine model [J]. Chin J Integrat Med, 2016, 22(2): 101-109.
10
Jin YY, Gao H, Zhang XY, et al. Shenfu injection inhibits inflammation in patients with acute myocardial infarction complicated by cardiac shock [J]. Chin J Integr Med, 2017, 23(3): 170-175.
11
Cao J, Zheng CD, Zhang GX, et al. Protective effect of Shenfu injection on myocardial mitochondria injured by ischemia-reperfusion in rabbits [J]. Chin Med J (Engl), 2005, 118(6): 505-507.
12
Zheng SY, Sun J, Zhao X, et al. Protective effect of Shenfu on myocardial ischemia-reperfusion injury in rats [J]. Am J Chin Med, 2004, 32(2): 209-209.
13
Singer M, Deutsehman CS, Seymour CW,et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) [J]. JAMA, 2016, 315(8): 801-810.
14
Xing X, Jiang R, Wang L, et al. Shenfu injection alleviates intestine epithelial damage in septic rats [J]. Am J Emerg Med, 2015, 33(11): 1665-1670.
15
Wang J, Qiao LF, Yang GT. Role of Shenfu injection in rats with systemic inflammatory response syndrome [J]. Chin J Integr Med, 2008, 14(1): 51-55.
16
Zhang N, Liu J, Qiu Z, et al. Shenfu injection for improving cellular immunity and clinical outcome in patients with sepsis or septic shock [J]. Am J Emerg Med, 2017, 35(1): 1-6.
17
Li MQ, Pan CG, Wang XM, et al. Effect of the shenfu injection combined with early goal-directed therapy on organ functions and outcomes of septic shock patients [J]. Cell Biochem Biophys, 2015, 72(3): 807-812.
18
Mou Z, Lv Z, Li Y, et al. Clinical effect of shenfu injection in patients with septic shock: a meta-analysis and systematic review [J]. Evid Based Complement Alternat Med, 2015, 2015: 863149.
19
Li Yi, Zhang XC, Lin PH, et al. Effects of Shenfu injection in the treatment of septic shock patients: a multicenter, controlled, randomized, open-label trial [J]. Evid Based Complement Alternat Med, 2016, 2016: 2565169.
20
中华医学会重症医学分会. 中国严重脓毒症/脓毒性休克治疗指南(2014) [J]. 中华内科杂志, 2015, 54(6): 557-581.
21
中国医师协会急诊医师分会,中国研究型医院学会休克与脓毒症专业委员会.中国脓毒症/脓毒性休克急诊治疗指南(2018) [J]. 中国急救医学, 2018, 38(9): 741-756.
22
邓永诚,董丽军. 参附注射液对心力衰竭患者心功能及血浆脑钠肽水平的影响 [J/CD]. 中华危重症医学杂志(电子版), 2010, 3(5): 17-19.
23
Song WT, Cheng FF, Xu L, et al. Chinese medicine shenfu injection for heart failure: a systematic review and meta-analysis [J]. Evid Based Complement Alternat Med, 2012, 2012: 713149.
24
叶淑. 参附注射液治疗急性心力衰竭疗效观察 [J]. 现代中西医结合杂志, 2016, 25(13): 1449-1451.
25
毕晓锋,刘国斌. 参附注射液治疗心源性休克的疗效观察 [J]. 实用临床医学, 2005, 6(9): 32-34.
26
张熹煜,钟敏莹. 参附注射液联合主动脉内球囊反搏术治疗心源性休克临床观察 [J]. 新中医, 2010, 42(9): 18-19.
27
Ji XF, Yang L, Zhang MY, et al. Shen-fu injection attenuates postresuscitation myocardial dysfunction in a porcine model of cardiac arrest [J]. Shock, 2011, 35(5): 530-536.
28
Zhang MY, Ji XF, Wang S, et al. Shen-fu injection attenuates postresuscitation lung injury in a porcine model of cardiac arrest [J]. Resuscitation, 2012, 83(9): 1152-1158.
29
Hou X, Li C, Gu W, et al. Effect of Shenfu on inflammatory cytokine release and brain edema after prolonged cardiac arrest in the swine [J]. Am J Emerg Med, 2013, 31(8): 1159-1164.
30
Zhang Q, Li C, Shao F, et al. Efficacy and safety of combination therapy of shenfu injection and postresuscitation bundle in patients with return of spontaneous circulation after in-hospital cardiac arrest: a randomized, assessor-blinded, controlled trial [J]. Crit Care Med, 2017, 45(10): 1587-1595.
31
Xia ZY, Liu X, Zhan LY, et al. Ginsenosides compound (shen-fu) attenuates gastrointestinal injury and inhibits inflammatory response after cardiopulmonary bypass in patients with congenital heart disease [J]. J Thorac Cardiovasc Surg, 2005, 130(2): 258-264.
32
Lv SJ, Lai DP, Wei X, et al. The protective effect of Shenfu injection against elderly severe pneumonia [J]. Eur J Trauma Emerg Surg, 2017, 43(5): 711-715.
33
Mo Y, Liu X, Qin X, et al. Shenfu injection for intradialytic hypotension: a systematic review and meta-analysis [J]. Evid Based Complement Alternat Med, 2014, 2014: 279853.
[1] 陆婷, 范晴敏, 王洁, 万晓静, 许春芳, 董凤林. 超声引导下经皮穿刺置管引流对重症急性胰腺炎的疗效及应用时机的选择[J/OL]. 中华医学超声杂志(电子版), 2024, 21(05): 511-516.
[2] 李博, 贾蓬勃, 李栋, 李小庆. ERCP与LCBDE治疗胆总管结石继发急性重症胆管炎的效果[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 60-63.
[3] 党军强, 杨雁灵, 汪庆强, 尚琳, 朱磊, 项红军. 主动经皮穿刺引流治疗重症急性胰腺炎并发急性坏死物积聚的疗效分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 671-674.
[4] 邵世锋, 肖钦, 沈方龙, 张迅, 郝志鹏, 伍正彬, 谢晓娟, 王耀丽. 老年胸主动脉钝性伤的重症救治分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 762-767.
[5] 于燕兴, 梅喜庆, 刘凤娟, 于梓薇, 许亚慧, 徐飞. 高通量测序重症肺炎肺泡灌洗液病原体的临床应用[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 785-788.
[6] 刘雯, 赵明栋, 夏伟, 潘以雄. 不同剂量比阿培南治疗重症肺炎的疗效分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 789-792.
[7] 潘冬生, 梁国标. 颅脑创伤治疗的最新进展与未来趋势[J/OL]. 中华神经创伤外科电子杂志, 2024, 10(04): 193-197.
[8] 姚庆春, 魏光晨, 孟玫. 关注ICU 患者接受的非必要血液检测[J/OL]. 中华重症医学电子杂志, 2024, 10(04): 329-333.
[9] 丛黎, 马林, 陈旭, 李文文, 张亮亮, 周华亭. 改良CT严重指数联合炎症指标在重症急性胰腺炎患者胰腺感染预测及预后评估中的研究[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(05): 432-436.
[10] 宋燕秋, 戚桂艳, 杨双双, 周萍. 重症急性胰腺炎肠道菌群特征及早期肠内营养联合微生态制剂治疗的临床价值[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(05): 442-447.
[11] 刘春峰, 徐朝晖, 施红伟, 陈瑢, 马腾飞, 李鹏飞, 袁蓉, 陈建荣, 徐爱明. 机械通气患者肌肉减少症的诊断及其对预后的影响[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 820-825.
[12] 董晟, 郎胜坤, 葛新, 孙少君, 薛明宇. 反向休克指数乘以格拉斯哥昏迷评分对老年严重创伤患者发生急性创伤性凝血功能障碍的预测价值[J/OL]. 中华临床医师杂志(电子版), 2024, 18(06): 541-547.
[13] 张平骥, 徐钰, 李天水, 庞文翼, 符师宁, 张梦圆. 重症患者镇静治疗现状及期望的调查研究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(06): 562-567.
[14] 詹维强, 李梦蝶, 涂玉玲, 郭艳, 芦乙滨, 史新格, 许明. 早期CRRT联合VA-ECMO治疗难治性心源性休克的临床效果[J/OL]. 中华卫生应急电子杂志, 2024, 10(05): 260-268.
[15] 李璇, 邓岚, 郭微, 邓永梅, 刘杰昕. 标准化皮肤管理流程在防治脑卒中患者失禁相关性皮炎中的应用[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(05): 479-482.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?